Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27,767,902
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
13,419,466
-
Shares change
-
+363,750
-
Total reported value, excl. options
-
$295,897,870
-
Value change
-
-$1,389,083
-
Put/Call ratio
-
89%
-
Number of buys
-
59
-
Number of sells
-
-83
-
Price
-
$22.05
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q2 2016
166 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q2 2016.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,419,466 shares
of 27,767,902 outstanding shares and own 48% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (1,201,932 shares), EAGLE ASSET MANAGEMENT INC (1,001,572 shares), Krensavage Asset Management, LLC (906,930 shares), FMR LLC (700,653 shares), ACADIAN ASSET MANAGEMENT LLC (690,136 shares), STATE STREET CORP (652,261 shares), VANGUARD GROUP INC (650,560 shares), Fiera Capital Corp (565,989 shares), GREAT POINT PARTNERS LLC (538,024 shares), and SENZAR ASSET MANAGEMENT, LLC (482,000 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.